April 2

BERLIN, April 2, 2011 - Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma (HCC), according to data presented at the International Liver Congress(TM) 2011.[1] To view the Multimedia News Release, please click: multivu.prnewswire.com/mnr/prne/easl/48894/ A new study found thalidomide gave HCC patients who'd undergone grossly curative resection - surgical removal of the cancerous part of the liver - double the two-year disease free survival rate (65%) compared to placebo (33%).

KYIV, Ukraine, April 2, 2011 - President of Ukraine Viktor Yanukovych has completed his state visits to Singapore, Vietnam and Brunei, where he called the Southeast Asian businesses to invest into the Ukraine's National Projects.

CHARENTON-LE-PONT, France, April 2, 2010 - Following approval by the US competition authorities, Essilor has completed its acquisition of Signet Armorlite, a leading independent manufacturer of ophthalmic lenses.

LONDON, April 2, 2010 - Bob Liddell, a private investor from Glasgow has achieved what some investors would call the impossible.

THE HAGUE, The Netherlands, April 2, 2010 - AEGON has completed the sale of its funeral insurance business in the Netherlands to Dutch investment firm Egeria for EUR 212 million.